Business Description
Roivant Sciences Ltd
ISIN : BMG762791017
Share Class Description:
STU:87S: Ordinary SharesDescription
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.98 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.08 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 12.32 | |||||
Beneish M-Score | -0.15 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 62.4 | |||||
3-Year EPS without NRI Growth Rate | -15.6 | |||||
3-Year FCF Growth Rate | -4.2 | |||||
3-Year Book Growth Rate | 41.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | 10.35 | |||||
Future 3-5Y Total Revenue Growth Rate | 67.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 73.76 | |||||
9-Day RSI | 67.05 | |||||
14-Day RSI | 62.03 | |||||
6-1 Month Momentum % | -6.65 | |||||
12-1 Month Momentum % | -4.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 27.91 | |||||
Quick Ratio | 27.75 | |||||
Cash Ratio | 26.41 | |||||
Days Inventory | 398.34 | |||||
Days Sales Outstanding | 121.55 | |||||
Days Payable | 1002.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.6 | |||||
Shareholder Yield % | 5.29 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 90.32 | |||||
Operating Margin % | -661.14 | |||||
Net Margin % | 2991.76 | |||||
FCF Margin % | -448.5 | |||||
ROE % | 122.36 | |||||
ROA % | 93.84 | |||||
ROIC % | -160.34 | |||||
ROC (Joel Greenblatt) % | 6533 | |||||
ROCE % | 97.7 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 2.12 | |||||
PS Ratio | 59.82 | |||||
PB Ratio | 1.6 | |||||
Price-to-Tangible-Book | 1.64 | |||||
EV-to-EBIT | 0.73 | |||||
EV-to-EBITDA | 0.73 | |||||
EV-to-Revenue | 21.58 | |||||
EV-to-Forward-Revenue | 10.06 | |||||
EV-to-FCF | -4.81 | |||||
Price-to-Net-Current-Asset-Value | 1.76 | |||||
Price-to-Net-Cash | 1.88 | |||||
Earnings Yield (Greenblatt) % | 136.99 | |||||
FCF Yield % | -8.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Roivant Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 146.655 | ||
EPS (TTM) (€) | 5.091 | ||
Beta | 0 | ||
Volatility % | 44.87 | ||
14-Day RSI | 62.03 | ||
14-Day ATR (€) | 0.169914 | ||
20-Day SMA (€) | 10.00575 | ||
12-1 Month Momentum % | -4.83 | ||
52-Week Range (€) | 7.85 - 12.3 | ||
Shares Outstanding (Mil) | 739.52 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Roivant Sciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Roivant Sciences Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Roivant Sciences Ltd Frequently Asked Questions
What is Roivant Sciences Ltd(STU:87S)'s stock price today?
The current price of STU:87S is €10.51. The 52 week high of STU:87S is €12.30 and 52 week low is €7.85.
When is next earnings date of Roivant Sciences Ltd(STU:87S)?
The next earnings date of Roivant Sciences Ltd(STU:87S) is 2024-11-13 Est..
Does Roivant Sciences Ltd(STU:87S) pay dividends? If so, how much?
Roivant Sciences Ltd(STU:87S) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |